ATE319997T1 - Screeningverfahren für modulatoren von integrinen - Google Patents

Screeningverfahren für modulatoren von integrinen

Info

Publication number
ATE319997T1
ATE319997T1 AT01402843T AT01402843T ATE319997T1 AT E319997 T1 ATE319997 T1 AT E319997T1 AT 01402843 T AT01402843 T AT 01402843T AT 01402843 T AT01402843 T AT 01402843T AT E319997 T1 ATE319997 T1 AT E319997T1
Authority
AT
Austria
Prior art keywords
integrins
modulators
screening process
methods
beta
Prior art date
Application number
AT01402843T
Other languages
English (en)
Inventor
Jacques Hamon
Emmanuel Normant
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE319997T1 publication Critical patent/ATE319997T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Optical Communication System (AREA)
  • Peptides Or Proteins (AREA)
AT01402843T 2001-11-05 2001-11-05 Screeningverfahren für modulatoren von integrinen ATE319997T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01402843A EP1308726B1 (de) 2001-11-05 2001-11-05 Screeningverfahren für Modulatoren von Integrinen

Publications (1)

Publication Number Publication Date
ATE319997T1 true ATE319997T1 (de) 2006-03-15

Family

ID=8182955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01402843T ATE319997T1 (de) 2001-11-05 2001-11-05 Screeningverfahren für modulatoren von integrinen

Country Status (4)

Country Link
EP (1) EP1308726B1 (de)
AT (1) ATE319997T1 (de)
DE (1) DE60117743T2 (de)
ES (1) ES2257388T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1687637A4 (de) * 2003-11-29 2007-09-05 Proteogen Inc Screening-verfahren mit hohem durchsatz für einen integrin-antagonisten und durch screening damit erhaltenes neues peptid
WO2007007151A2 (en) * 2005-07-11 2007-01-18 Pfizer Limited Use of anti-mad-cam antibody for the treatment of emphysema
WO2011103049A2 (en) * 2010-02-16 2011-08-25 Immune Disease Institute, Inc. Method for screening receptors/ligands interactions
DE102017114537A1 (de) * 2017-06-29 2019-01-03 Endress+Hauser Conducta Gmbh+Co. Kg Sensormembran, Sensorkappe und optischer Sensor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837478A (en) * 1993-12-23 1998-11-17 Icos Corporation Method of identifying modulators of binding between and VCAM-1
CA2224571A1 (en) * 1996-04-15 1997-10-23 Icos Corporation Cytoplasmic modulators of integrin regulation/signaling
EP1078006B1 (de) * 1998-05-13 2009-03-04 Genentech, Inc. Diagnose und behandlung von hepatischen krankheiten

Also Published As

Publication number Publication date
EP1308726A1 (de) 2003-05-07
ES2257388T3 (es) 2006-08-01
DE60117743D1 (de) 2006-05-04
EP1308726B1 (de) 2006-03-08
DE60117743T2 (de) 2006-10-12

Similar Documents

Publication Publication Date Title
DE69630214D1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
DE69527987D1 (de) Formulierungen und verfahren zur reduzierung von hautreizung
NO20010446L (no) Substituert anilidforbindelser og metoder
DE69434313D1 (de) Superoxiddismutase memetika
ATE319823T1 (de) Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
ATE490758T1 (de) Färbezusammensetzung enthaltend einen bestimmten hydrophoben farbstoff und eine säure
DE60042066D1 (de) Chimärische dr4 antikörper und ihre verwendung
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
ATE234812T1 (de) Integrin antagonisten
DE69934998D1 (de) Antisense modulation der expression von integrin alpha 4
ATE525480T1 (de) Verwendung von a33-antigenen und jam-it
DE602004031458D1 (de) Verfahren zur erhöhung der refinerproduktionsrate und/oder verringerung der spezifischen energie des aufschliessens von holz
DE60239467D1 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ATE319997T1 (de) Screeningverfahren für modulatoren von integrinen
DE59010919D1 (de) N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
DE60102539D1 (de) Verfahren und Zusammensetzungen zum Screenen von Modulatoren von Sphingosinkinasen
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
DE60327543D1 (de) Substituierte tetraline und indane und ihre verwendung
ATE229069T1 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
DE69917445D1 (de) Reinigung von carboxaldehyd

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties